摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-(+)-N-acetylolchinol | 38838-26-5

中文名称
——
中文别名
——
英文名称
(R)-(+)-N-acetylolchinol
英文别名
(+)-N-acetylcolchinol;(R)-N-acetylcolchinol;N-Acetylcolchicinol;N-[(8R)-5-hydroxy-13,14,15-trimethoxy-8-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl]acetamide
(R)-(+)-N-acetylolchinol化学式
CAS
38838-26-5
化学式
C20H23NO5
mdl
——
分子量
357.406
InChiKey
WJJZQSCOTJYYSP-MRXNPFEDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    213-215 °C
  • 沸点:
    490.03°C (rough estimate)
  • 密度:
    1.2532 (rough estimate)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    26
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    77
  • 氢给体数:
    2
  • 氢受体数:
    5

SDS

SDS:4d86449f46c32a70da4050f1c2282c8a
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Asymmetric synthesis of (S)-(−)-N-acetylcolchinol via Ullmann biaryl coupling
    作者:Simon D. Broady、Michael D. Golden、John Leonard、James C. Muir、Mickael Maudet
    DOI:10.1016/j.tetlet.2007.04.103
    日期:2007.6
    A modified Ziegler Ullmann coupling process has been developed as the key step in an effective synthesis of (S)-(−)-N-acetylcolchinol, analogues of which are selective vascular targeting agents with potential importance in cancer chemotherapy. Asymmetric induction is achieved by enamide hydrogenation using FerroTANE catalysts.
    已开发出改良的Ziegler Ullmann偶联工艺,作为有效合成(S)-(-)- N-乙酰胆碱醇的关键步骤,其类似物是选择性血管靶向剂,在癌症化疗中具有潜在的重要性。不对称诱导是通过使用FerroTANE催化剂进行的酰胺氢化来实现的。
  • Short electrochemical asymmetric synthesis of (+)-<i>N</i>-acetylcolchinol
    作者:Yi Du、Adelaide Lunga、Aleksandr E. Rubtsov、Andrei V. Malkov
    DOI:10.1039/d2gc02321k
    日期:——
    A short synthesis of N-acetylcolchinol using a greener and step-economical pathway is reported where all the redox reactions, except for the asymmetric reduction, were carried out electrochemically, replacing protocols that employ transition metals or stoichiometric hazardous reagents. In a 4-step racemic sequence, chemoselective reduction of chalcone and intramolecular oxidative arene–arene coupling
    据报道,使用更环保和步骤经济的途径合成N-乙酰基秋仙醇,其中除不对称还原外的所有氧化还原反应均以电化学方式进行,取代了使用过渡属或化学计量危险试剂的方案。在 4 步外消旋序列中,化学选择性还原查尔酮和分子内氧化芳烃 - 芳烃偶联在电化学电池中进行,得到目标N-乙酰秋仙醇,总产率为 41%。在 7 步不对称变体中,电化学也用于对甲氧基苯胺的脱保护。以 33% 的总产率和 99.5 : 0.5 er 获得目标化合物。
  • Asymmetric enamide hydrogenation in the synthesis of N-acetylcolchinol: a key intermediate for ZD6126
    作者:Ian C. Lennon、James A. Ramsden、Catherine J. Brear、Simon D. Broady、James C. Muir
    DOI:10.1016/j.tetlet.2007.04.090
    日期:2007.6
    A synthesis of N-acetylcolchinol, a key intermediate in the synthesis of ZD6126, was developed. The enantiodifferentiating step required the catalytic asymmetric hydrogenation of an enamide. After screening a range of metal and ligand combinations it was found that (S,S)-iPr–FerroTANE Ru(methallyl)2 and [(S,S)-tBuFerroTANE Rh(COD)]BF4 gave both high enantioselectivity (>90% ee) and high catalyst utility
    开发了N-乙酰基胆的合成方法,该合成方法是ZD6126合成中的关键中间体。对映异构化步骤需要烯酰胺的催化不对称氢化。在筛选了一系列属和配体组合后,发现(S,S)-i Pr–FerroTANE Ru(甲基烯丙基)2和[(S,S)-t BuFerroTANE Rh(COD)] BF 4都具有很高的对映选择性( ee> 90%)和高催化剂利用率(摩尔比S / C  = 1000)。
查看更多

同类化合物

别秋水仙碱 N-乙酰基秋水仙醇甲基醚 ANG 453; N-[(5S)-6,7-二氢-9,10,11-三甲氧基-3-(磷酰氧基)-5H-二苯并[a,c]环庚烯-5-基]乙酰胺 N-[(5S)-3-(2-tert-butoxycarbonylethylcarbamoyl)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[3-amino-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[3-((N-benzyloxycarbonylalanyl)amino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[(5S)-3-(2-morpholinoethoxycarbonyl)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[(5S)-3-(2-morpholinoethoxy)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-(1,2,3,9,10-pentamethoxy-5,6-dihydro-7H-dibenzo[a,c][7]annulen-7-yl)acetamide N-(10-fuoro-9-hydroxy-1,2,3-trimethoxy-5,6-dihydro-7H-dibenzo[a,c][7]annulen-7-yl)acetamide (5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl ethyl hydrogen phosphate N-[(5S)-3-phenoxycarbonyloxy-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide (5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl hydrogenmethylphosphonate 4-[([(5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl]oxycarbonyl)amino]butanoic acid 4-[([(5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl]aminocarbonyl)amino]butanoic acid 5-[{(5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl}oxycarbonyl]pentanoic acid N-[(5S)-3-(2,3-epoxypropoxy)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-(6-cyano-7-hydroxy-6-(ethoxymethyl)-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-yl)benzamide N-(6-cyano-7-hydroxy-6-(methoxymethyl)-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-yl)benzamide N-(6-cyano-3-fluoro-7-hydroxy-6-(isopropoxymethyl)-6,7-dihydro-5Hdibenzo[a,c][7]annulen-5-yl)benzamide ethyl 5-benzamido-7-hydroxy-6-(isopropoxymethyl)-6,7-dihydro-5Hdibenzo[a,c][7]annulene-6-carboxylate ethyl 5-benzamido-6-(ethoxymethyl)-7-hydroxy-6,7-dihydro-5H-dibenzo[a,c][7]annulene-6-carboxylate N-(6-cyano-7-hydroxy-6-(isopropoxymethyl)-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-yl)furan-2-carboxamide (5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl hydrogensulphate N-[(5S)-3-(N,N-dimethylaminoacetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[(5S)-9,10,11-trimethoxy-3-([(3-morpholinopropyl)amino]carbonylamino)-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[(5S)-3-phenoxycarbonylamino-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide (5S)-5-(acetylamino)-9,10,11-trimethoxy-N-(3morpholinopropyl)-6,7-dihydro-5H-dibenzo[a,c]cycloheptene-3-carboxamide (5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl methyl carbonate N-((1S)-2''-(8-(metoxycarbonyl)octyl)-1',2',3'-trimetoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(pyridin-2-yl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(2-hydroxyethyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(acetoxymethyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-((diethylamino)methyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(1-hydroxycyclopentyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(hydroxymethyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(1-hydroxyethyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide 1'-bromo-2',3',4'-trimethoxybenzo[5',6':4,5]-1H-(aR,1S)-1-acetamido-6,7-dihydrocyclohepta[3, 4-f]-1H-2-hydroxymethylindole 2-chloro-N-(6-cyano-7-hydroxy-6-(isopropoxymethyl)-6,7-dihydro-5Hdibenzo[a,c][7]annulen-5-yl)benzamide (R)-(+)-N-acetylolchinol 5-[N'-(3,5-difluorophenylacetyl)-L-alaninyl]amino-5,7-dihydro-6H-dibenzo[a,c]cyclohepten-6-ol N-(3,9,10,11-tetramethoxy-7-oxo-6,7-dihydro-5H-dibenzo [a,c][7]cyclohepten-5-yl)-2,2,2-trifluoroacetamide (S)-7-acetamido-6,7-dihydro-1,2,3-trimethoxy-7H-dibenzocycloheptene N-(2-iodo-3,9,10,11-tetramethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl)-acetamide N-(9,10-dimethoxy-7-oxo-6,7-dihydro-5H-dibenzo[a,c][7]cyclohepten-5-yl)-2,2,2-trifluoroacetamide N-(9-hydroxy-1,2,3-trimethoxy-5,6-dihydro-7H-di-benzo[a,c][7]annulen-7-yl)acetamide N-(1,2,3,9-tetramethoxy-5,6-dihydro-7H-dibenzo[a,c][7]annulen-7-yl)acetamide N-(3-hydroxy-9,10-dimethoxy-7-oxo-6,7-dihydro-5H-dibenzo[a,c][7]cyclohepten-5-yl)-2,2,2-trifluoroacetamide N-(3-hydroxy-9,10,11-trimethoxy-7-oxo-6,7-dihydro-5H-dibenzo[a,c][7]cyclohepten-5-yl)-2,2,2-trifluoroacetamide N-(3-hydroxy-2-iodo-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl)-acetamide